Rhinoplasty surgery. Encounter for cosmetic surgery
Conditions
Interventions
Intervention 1: Intervention group: In the Intervention group one patients will receive 1 µg / kg dexmedetomidine (PFIZER, USA) for 20 minutes and at the same time as induction begins with a dose of 0
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: 18-45 years old Patients undergoing rhinoplasty surgery time of surgery is 7-10 days before menstruation time
Exclusion criteria
Exclusion criteria: Patients with liver dysfunction Renal dysfunction Any known allergy or hypersensitivity to study drugs Abuse of analgesics and any addiction to opioid, Diabetes mellitus Hemorrhagic disease Using anticoagulants Cerebrovascular disease Heart block Cardiovascular disease Morbid obesity Females whom experience nausea and vomiting in their menstrual cycle Revision rhinoplasty surgery
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Patients’ satisfactions. Timepoint: After injection of intervention drugs in the recovery room and surgery ward. Method of measurement: Likert Scale.;Surgeon’ satisfactions. Timepoint: At the end of the surgery. Method of measurement: Likert Scale. | — |
Primary
| Measure | Time frame |
|---|---|
| Amount of intraoperative bleeding. Timepoint: At the end of the surgery. Method of measurement: Observasion.;Post operative pain. Timepoint: At arrival to the recovery room and at, 45,30,15 minutes. Method of measurement: Visual analogue Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Nemati
Shiraz University of Medical Sciences
Outcome results
None listed